Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2280]
News [5229]
Articles [128]
Editorials [4]
Conferences [157]
elearning [13]
Deadly ovarian cancer outsmarts chemotherapy
Deadly ovarian cancer outsmarts chemotherapy
ASCO 2015: Adding elotuzumab significantly reduces risk of progression for relapsed multiple myeloma
ASCO 2015: Adding elotuzumab significantly reduces risk of progression for relapsed multiple myeloma
Mortality and incidence for most breast cancer subtypes continue to decline
Mortality and incidence for most breast cancer subtypes continue to decline
Trial of new ‘resistance-busting’ skin cancer drug begins as first patient receives treatment
Trial of new ‘resistance-busting’ skin cancer drug begins as first patient receives treatment
Multiple types of resistance to new lung cancer drug identified
Multiple types of resistance to new lung cancer drug identified
Study points to possible treatment for lethal paediatric brain cancer
Study points to possible treatment for lethal paediatric brain cancer
The anti-CTLA-4 antibody ipilimumab targets regulatory T cells in melanoma patients
The anti-CTLA-4 antibody ipilimumab targets regulatory T cells in melanoma patients
Four subgroups defined for gastric cancer
Four subgroups defined for gastric cancer
Mouse models show tailored immunotherapy to be effective
Mouse models show tailored immunotherapy to be effective
AACR 2015: PARP inhibitor combo shows early promise for patients with and without BRCA mutations
AACR 2015: PARP inhibitor combo shows early promise for patients with and without BRCA mutations

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation